205 related articles for article (PubMed ID: 23321827)
1. Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors.
Sharma A; Lanuti M; He W; Palmer EL; Shepard JA; Digumarthy SR
J Comput Assist Tomogr; 2013; 37(1):9-14. PubMed ID: 23321827
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.
Okuma T; Okamura T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Koyama K; Inoue K; Nakamura K; Inoue Y
Ann Nucl Med; 2006 Feb; 20(2):115-21. PubMed ID: 16615420
[TBL] [Abstract][Full Text] [Related]
4. Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor.
Higaki F; Okumura Y; Sato S; Hiraki T; Gobara H; Mimura H; Akaki S; Tsuda T; Kanazawa S
Ann Nucl Med; 2008 Apr; 22(3):157-63. PubMed ID: 18498029
[TBL] [Abstract][Full Text] [Related]
5. The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
Alafate A; Shinya T; Okumura Y; Sato S; Hiraki T; Ishii H; Gobara H; Kato K; Fujiwara T; Miyoshi S; Kaji M; Kanazawa S
Acta Med Okayama; 2013; 67(2):105-12. PubMed ID: 23603927
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
7. Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
Bollineni VR; Widder J; Pruim J; Langendijk JA; Wiegman EM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e551-5. PubMed ID: 22417800
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.
Okuma T; Matsuoka T; Okamura T; Wada Y; Yamamoto A; Oyama Y; Koyama K; Nakamura K; Watanabe Y; Inoue Y
J Nucl Med; 2006 Aug; 47(8):1351-8. PubMed ID: 16883016
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of pre-radiofrequency ablation SUV(max) in 18F-FDG PET/CT to predict the risk of a local recurrence of malignant lung tumors after lung radiofrequency ablation.
Harada S; Sato S; Suzuki E; Okumura Y; Hiraki T; Gobara H; Mimura H; Kanazawa S; Kaji M; Fujiwara T
Acta Med Okayama; 2011 Dec; 65(6):395-402. PubMed ID: 22189480
[TBL] [Abstract][Full Text] [Related]
10. Reversible locoregional lymph node enlargement after radiofrequency ablation of lung tumors.
Sharma A; Digumarthy SR; Kalra MK; Lanuti M; Shepard JA
AJR Am J Roentgenol; 2010 May; 194(5):1250-6. PubMed ID: 20410411
[TBL] [Abstract][Full Text] [Related]
11. PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
Sainani NI; Shyn PB; Tatli S; Morrison PR; Tuncali K; Silverman SG
J Vasc Interv Radiol; 2011 Mar; 22(3):354-60. PubMed ID: 21353987
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?
Yoo DC; Dupuy DE; Hillman SL; Fernando HC; Rilling WS; Shepard JA; Siegel BA
AJR Am J Roentgenol; 2011 Aug; 197(2):334-40. PubMed ID: 21785078
[TBL] [Abstract][Full Text] [Related]
13. Dual time-point (18)F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases.
Lafuente S; Fuster D; Arguis P; Granados U; Perlaza P; Paredes P; Vollmer I; Sánchez M; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2016; 35(4):226-31. PubMed ID: 26848142
[TBL] [Abstract][Full Text] [Related]
14. Detection of local tumor progression by (18)F-FDG PET/CT following lung radiofrequency ablation: PET versus CT.
Suzawa N; Yamakado K; Takao M; Taguchi O; Yamada T; Takeda K
Clin Nucl Med; 2013 Apr; 38(4):e166-70. PubMed ID: 23429399
[TBL] [Abstract][Full Text] [Related]
15. Role of PET/Computed Tomography in Radiofrequency Ablation for Malignant Pulmonary Tumors.
Higuchi M; Suzuki H; Gotoh M
PET Clin; 2016 Jan; 11(1):47-55. PubMed ID: 26590443
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET.
Higuchi M; Honjo H; Shigihara T; Shishido F; Suzuki H; Gotoh M
J Cancer Res Clin Oncol; 2014 Nov; 140(11):1957-63. PubMed ID: 24952227
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.
Schoellnast H; Larson SM; Nehmeh SA; Carrasquillo JA; Thornton RH; Solomon SB
Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S182-5. PubMed ID: 20508937
[TBL] [Abstract][Full Text] [Related]
18. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
Huang YE; Chen CF; Huang YJ; Konda SD; Appelbaum DE; Pu Y
Acta Radiol; 2010 Sep; 51(7):782-8. PubMed ID: 20707663
[TBL] [Abstract][Full Text] [Related]
19. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
20. Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET.
Obrzut S; Pham RH; Vera DR; Badran K; Hoha CK
Nucl Med Commun; 2007 Jan; 28(1):7-13. PubMed ID: 17159543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]